Your browser doesn't support javascript.
loading
The Perception of the Müller-Lyer Visual Illusion in Schizophrenics and Non-human Primates: A Translational Approach.
Costa, Ana Luísa Lamounier; Silva, Ronaldo Coelho; Coelho-Cordeiro, Pedro H; da Silveira, Fernando Silva; Barros, Marilia; Caixeta, Fabio Viegas; Maior, Rafael S.
Afiliação
  • Costa ALL; Primate Center, Institute of Biology, University of Brasília, Brasilia, Brazil.
  • Silva RC; Laboratory of Neuroscience and Behavior, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, Brasilia, Brazil.
  • Coelho-Cordeiro PH; Primate Center, Institute of Biology, University of Brasília, Brasilia, Brazil.
  • da Silveira FS; Laboratory of Neuroscience and Behavior, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, Brasilia, Brazil.
  • Barros M; Primate Center, Institute of Biology, University of Brasília, Brasilia, Brazil.
  • Caixeta FV; Laboratory of Neuroscience and Behavior, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, Brasilia, Brazil.
  • Maior RS; Primate Center, Institute of Biology, University of Brasília, Brasilia, Brazil.
Front Behav Neurosci ; 15: 641776, 2021.
Article em En | MEDLINE | ID: mdl-34122024
The Müller-Lyer Illusion (MLI) has been suggested as a potential marker for the perceptual impairments observed in schizophrenia patients. Along with some positive symptoms, these deficits are not easily modeled in rodent experiments, and novel animal models are warranted. Previously, MK-801 was shown to reduce susceptibility to MLI in monkeys, raising the prospects of an effective perception-based model. Here, we evaluate the translational feasibility of the MLI task under NMDA receptor blockage as a primate model for schizophrenia. In Experiment 1, eight capuchin monkeys (Sapajus spp.) were trained on a touchscreen MLI task. Upon reaching the learning criteria, the monkeys were given ketamine (0.3 mg/kg; i.m.) or saline on four consecutive days and then retested on the MLI task. In Experiment 2, eight chronic schizophrenia patients (and eight matching controls) were tested on the Brentano version of the MLI. Under saline treatment, monkeys were susceptible to MLI, similarly to healthy human participants. Repeated ketamine administrations, however, failed to improve their performance as previous results with MK-801 had shown. Schizophrenic patients, on the other hand, showed a higher susceptibility to MLI when compared to healthy controls. In light of the present and previous studies, the MLI task shows consistent results across monkeys and humans. In spite of potentially being an interesting translational model of schizophrenia, the MLI task warrants further refinement in non-human primates and a broader sample of schizophrenia subtypes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Behav Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Behav Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça